Federal authorities move to close mammoth drug-pricing loophole

Years after the potential for abuse was flagged in Ohio, the federal agency that oversees Medicaid is moving to close a loophole that likely is worth billions to prescription drug middlemen.

The Centers for Medicare and Medicaid Services on Friday proposed a new rule that it said would help ensure compliance with a requirement under federal law that Medicaid dollars be spent in “proper and efficient” ways. Interested parties will have until late July to comment on the proposal.

Read the full story >